Company Filing History:
Years Active: 2021
Title: Innovations of Liesbeth Mudde-Boer
Introduction
Liesbeth Mudde-Boer is a prominent inventor based in Breitenfurt, Austria. She has made significant contributions to the field of immunology, particularly in the development of innovative compositions and connectors for medical applications. With a total of 2 patents, her work is paving the way for advancements in cancer treatment.
Latest Patents
One of her latest patents is an immunogenic composition targeting Her2/neu positive tumor diseases. This invention includes a directed adjuvant that comprises an anti-CD32 moiety linked to a TLR9 ligand and a first peptidic alpha-helix. Additionally, it features an immunogen that consists of an extracellular Her2/neu domain linked to a second peptidic alpha-helix coiled to the first alpha-helix. The invention also provides a kit for producing this immunogenic composition, along with a vaccine and its medical applications.
Another notable patent is the coiled-coil connector, which connects two molecules through a helical coiled coil-type structure. This connector features a peptidic first alpha-helix and a second peptidic alpha-helix, allowing for the connection of polypeptide chains in multimeric proteins. The design includes specific amino acid motifs that enhance the functionality of the connector.
Career Highlights
Liesbeth Mudde-Boer is currently associated with Oncoqr ML GmbH, where she continues to innovate in the field of cancer research. Her work is characterized by a strong focus on developing solutions that can significantly impact patient care and treatment outcomes.
Collaborations
Throughout her career, Liesbeth has collaborated with notable professionals in her field, including Geert Mudde and Jorge Sepulveda. These collaborations have contributed to her success and the advancement of her research.
Conclusion
Liesbeth Mudde-Boer is a trailblazer in the field of immunology, with her innovative patents and contributions to cancer treatment. Her work exemplifies the impact of dedicated research and collaboration in advancing medical science.